BACKGROUND Portal vein thrombosis is a frequent complication in end-stage cirrhosis with a considerable peri-operative risk for liver transplant candidates. We aimed to characterize the pre-transplant portal vein thrombosis in a cohort of liver transplant recipients, and to identify independent risk factors for this complication. METHODS 380 consecutive primary orthotopic liver transplants we...

During percutaneous coronary revascularization, intracoronary stents are effective in the treatment of abrupt vessel closure and improvement of suboptimal angioplasty results, and compared to balloon angioplasty, they reduce stenosis recurrence. Opposing these benefits, subacute thrombosis of stents is associated with a substantial increase in periprocedural morbidity and mortality. To review f...

deep vein thrombosis (dvt) and pulmonary embolism (pte) are known as venous thromboembolism (vte). dvt occurs when a thrombus (a blood clot) forms in deep veins of the body, usually in the lower extremities. it can cause swelling or leg pain, but sometimes may occur with no symptoms. awareness of dvt is the best way to prevent the vte. patients with trauma are at increased risk of dvt and subse...

Antiphospholipid antibodies are a wide and heterogeneous group of immunoglobulins, whose presence inpatients with arterial and venous thrombosis, and obstetrical complications defines the antiphospholipid syndrome. We systematically reviewed published articles on this syndrome to investigate the association between thrombosis and the most common antiphospholipid antibodies. Lupus anticoagulants...

Percutaneous coronary intervention with stent placement is one of the most frequently performed procedures in the western world. Patients with coronary stents need to be on dual antiplatelet therapy in order to minimize the risk of stent thrombosis. When these patients undergo surgical procedures, the risk of stent thrombosis needs to be balanced against the risk of bleeding in the perioperativ...

To analyze inherited antithrombin deficiency as a risk factor for venous thromboembolism in various conditions with regard to the presence or absence of additional genetic or acquired risk factors, we compared 48 antithrombin-deficient individuals with 44 nondeficient individuals of 14 selected families with inherited antithrombin deficiency. The incidence of venous thromboembolism for antithro...

To analyze inherited antithrombin deficiency as a risk factor for venous thromboembolism in various conditions with regard to the presence or absence of additional genetic or acquired risk factors, we compared 48 antithrombin-deficient individuals with 44 nondeficient individuals of 14 selected families with inherited antithrombin deficiency. The incidence of venous thromboembolism for antithro...

CONTEXT Postmenopausal hormone therapy increases the risk of venous thrombosis. It is not known whether other factors influencing thrombosis add to this risk. OBJECTIVE To report final data on incidence of venous thrombosis in the Women's Health Initiative Estrogen Plus Progestin clinical trial and the association of hormone therapy with venous thrombosis in the setting of other thrombosis ri...

Aim To describe the incidence of term and preterm neonatal cerebral sinovenous thrombosis (CSVT) identify perinatal risk factors. Method This was a national capture-recapture calculation-corrected surveillance nested case–control study. Infants born at with magnetic resonance imaging-confirmed CSVT were identified by in all paediatric hospitals Germany (2015–2017). Incidence corrected for under...

Celiac artery thrombosis with ischemia is a rare condition associated with risk factors for thrombosis or embolism. The manifestation is rare because of the large number of collaterals between the coeliac and superior mesenteric artery. Advanced pancreatic cancer may cause gradual occlusion with collaterals which needs special attention during pancreaticoduodenectomy. No case was reported with ...